286610816	286610816	CD	B-NP	O
|	|	NNP	I-NP	O
SHMC	SHMC	NNP	I-NP	O
|	|	VBD	B-VP	O
49352101	49352101	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9699782	9699782	CD	B-NP	O
|	|	CC	I-NP	O
4/9/2006	4/9/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
multilobar	multilobar	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/10/2006	6/10/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/10/2006	3/10/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
LALLEY	LALLEY	NNP	B-NP	O
,	,	,	O	O
WALLY	WALLY	NNP	B-NP	O
397-03-16-3	397-03-16-3	CD	I-NP	O
Rock	Rock	NNP	I-NP	O
Como	Como	NNP	I-NP	O
Amil	Amil	NNP	I-NP	O
Room	Room	NNP	I-NP	O
:	:	:	O	O
Troitmode	Troitmode	NNP	B-NP	O
Fran	Fran	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
1/4/06	1/4/06	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Home	Home	NNP	I-NP	O
services	service	NNS	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KITSMILLER	KITSMILLER	NNP	B-NP	O
,	,	,	O	O
TONEY	TONEY	NNP	B-NP	O
GALE	GALE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
650	650	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Headache	Headache	NNP	I-NP	I-protein
ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	I-NP	I-protein
ACID	ACID	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
DULCOLAX	DULCOLAX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
BISACODYL	BISACODYL	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Constipation	Constipation	NNP	I-NP	I-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LOVENOX	LOVENOX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
145	145	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/29/06	10/29/06	CD	B-NP	O
by	by	IN	B-PP	O
MATHRE	MATHRE	NN	B-NP	O
,	,	,	O	O
DOMINIQUE	DOMINIQUE	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
QHS	QHS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
012253563	012253563	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FENOFIBRATE	FENOFIBRATE	NNP	B-NP	O
,	,	,	I-NP	O
MICRONIZED	MICRONIZED	NNP	I-NP	O
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
IRON	IRON	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FERROUS	FERROUS	NNP	I-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
milk	milk	NN	I-NP	O
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
NOVOLOG	NOVOLOG	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
ASPART	ASPART	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
12	12	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
AC	AC	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
3/23	3/23	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
LANTUS	LANTUS	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
44	44	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/23	3/23	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ATROVENT	ATROVENT	NN	I-NP	B-protein
NEBULIZER	NEBULIZER	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
IPRATROPIUM	IPRATROPIUM	NN	I-NP	I-protein
NEBULIZER	NEBULIZER	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
0.5	0.5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
NEB	NEB	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
KEPPRA	KEPPRA	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LEVETIRACETAM	LEVETIRACETAM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

ZANTAC	ZANTAC	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
RANITIDINE	RANITIDINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
MULTIVITAMIN	MULTIVITAMIN	NNP	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	I-protein
MULTIVI	MULTIVI	NNP	I-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/29/06	10/29/06	CD	B-NP	O
by	by	IN	B-PP	O
HOLTZER	HOLTZER	NN	B-NP	O
,	,	,	O	O
MARTIN	MARTIN	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
QHS	QHS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
012253563	012253563	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/9/06	7/9/06	CD	B-NP	O
by	by	IN	B-PP	O
DOERSAM	DOERSAM	NNP	B-NP	O
,	,	,	O	O
JAN	JAN	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
298644458	298644458	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/10/06	4/10/06	CD	B-NP	O
by	by	IN	B-PP	O
CUPIT	CUPIT	NNP	B-NP	O
,	,	,	O	O
ADALBERTO	ADALBERTO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/25/06	10/25/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
FENOFIBRATE	FENOFIBRATE	NNP	B-NP	O
,	,	,	I-NP	O
MICRONIZED	MICRONIZED	NNP	I-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Lewis	Lewis	NNP	B-NP	O
Mozdzierz	Mozdzierz	NNP	I-NP	O
2/22/06	2/22/06	CD	I-NP	O
13	13	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Stirgus	Stirgus	NNP	B-NP	O
7/14/06	7/14/06	CD	I-NP	O
15	15	CD	I-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Tune	Tune	NNP	I-NP	O
8/18/06	8/18/06	CD	I-NP	O
14	14	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
PHENYTOIN	PHENYTOIN	NN	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
,	,	,	O	O
PHENYTOIN	PHENYTOIN	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
hypoxia	hypoxia	NN	B-NP	O
,	,	,	O	O
hypotension	hypotension	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
multilobar	multilobar	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CVA	CVA	NNP	I-NP	O
DM	DM	NNP	I-NP	O
CAD	CAD	NNP	I-NP	O
GERD	GERD	NNP	I-NP	O
HTN	HTN	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NNP	I-NP	O
and	and	CC	O	O
Sisouth	Sisouth	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
MVR	MVR	NNP	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
sacral	sacral	JJ	I-NP	O
decub	decub	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	O	O
diuresis	diuresis	NN	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
cc	cc	NN	B-NP	O
:	:	:	O	O
multilobar	multilobar	JJ	B-NP	O
pna	pna	NN	I-NP	O
,	,	,	O	O
hypotension	hypotension	NN	B-NP	O
,	,	,	O	O
MICU	MICU	NN	B-NP	O
call-out	call-out	NN	I-NP	O
***	***	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
66	66	CD	B-NP	O
yo	yo	NN	I-NP	O
male	male	JJ	B-ADJP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DMII	DMII	NN	B-NP	B-protein
,	,	,	O	O
hyperlipid	hyperlipid	NN	B-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	B-protein
CMP	CMP	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
EF	EF	NN	I-NP	I-protein
35	35	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	O
CVA	CVA	NNP	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
admit	admit	NN	I-NP	O
4/25	4/25	CD	I-NP	O
for	for	IN	B-PP	O
RML	RML	NN	B-NP	O
pna	pna	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
day	day	NN	I-NP	O
hosp	hosp	NN	I-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
felt	feel	VBD	B-VP	O
fine	fine	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
some	some	DT	B-NP	O
waxing	waxing	NN	I-NP	O
and	and	CC	I-NP	O
waning	waning	NN	I-NP	O
.	.	.	O	O

Increased	Increase	VBN	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
rigors	rigor	NNS	B-NP	O
,	,	,	O	O
difficulty	difficulty	NN	B-NP	O
walking/speaking	walking/speake	VBG	B-VP	O
,	,	,	O	O
fever	fever	NN	B-NP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
blue	blue	JJ	B-NP	B-protein
lips/hands	lips/hand	NNS	I-NP	I-protein
per	per	IN	B-PP	I-protein
family	family	NN	B-NP	I-protein
.	.	.	O	O

EMS	EMS	NNS	B-NP	O
called	call	VBN	B-VP	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
NRB	NRB	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
showed	show	VBD	B-VP	O
new	new	JJ	B-NP	O
LBBB	LBBB	NN	I-NP	B-protein
but	but	CC	I-NP	O
cath	cath	NN	I-NP	O
lab	lab	NN	I-NP	O
did	do	VBD	B-VP	O
declined	decline	VBN	I-VP	O
to	to	TO	I-VP	O
intervene	intervene	VB	I-VP	O
saying	say	VBG	I-VP	O
likely	likely	JJ	B-NP	O
2ary	2ary	JJ	I-NP	O
demand	demand	NN	I-NP	O
.	.	.	O	O

Hypotensive	Hypotensive	JJ	B-ADJP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
required	require	VBD	B-VP	O
fluids	fluid	NNS	B-NP	O
,	,	,	O	O
SCL	SCL	NN	B-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
placed	place	VBN	B-VP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
3V	3V	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
X	X	NN	I-NP	O
1	1	CD	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
SVG	SVG	NN	I-NP	B-protein
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
NSTEMI	NSTEMI	NN	B-NP	B-protein
11/19	11/19	CD	I-NP	I-protein
with	with	IN	B-PP	O
cypher	cypher	NN	B-NP	O
to	to	TO	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
prox	prox	NN	I-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	I-NP	O
pixel	pixel	NN	I-NP	O
to	to	TO	B-PP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
ostial	ostial	JJ	I-NP	O
D1	D1	NN	I-NP	O
,	,	,	O	O
NSTEMI	NSTEMI	NN	B-NP	B-protein
11/1	11/1	CD	I-NP	I-protein
,	,	,	O	O
new	new	JJ	B-NP	O
cypher	cypher	NN	I-NP	O
to	to	TO	B-PP	O
D1	D1	NN	B-NP	O
instent	instent	JJ	I-NP	O
restenosis	restenosis	NN	I-NP	O
,	,	,	O	O
diffuse	diffuse	JJ	B-NP	O
LCx	LCx	NN	I-NP	O
disease	disease	NN	I-NP	O
;	;	:	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DMII	DMII	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
agents	agent	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
hyperlipid	hyperlipid	NN	B-NP	O
,	,	,	O	O
MR	MR	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	O
Na	Na	NNP	I-NP	O
Ci	Ci	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
33mm	33mm	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
EF35	EF35	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
multiple	multiple	JJ	B-NP	O
CVA	CVA	NN	I-NP	O
's	's	POS	B-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
on	on	IN	B-PP	O
Rx	Rx	NN	B-NP	B-protein
dose	dose	NN	I-NP	I-protein
lovenox	lovenox	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
SDH	SDH	NN	B-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
9s/p	9s/p	CD	I-NP	O
Burr	Burr	NNP	I-NP	O
hole	hole	NN	I-NP	O
drainage	drainage	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
seizure	seizure	NN	B-NP	O
d/o	d/o	NN	I-NP	O
;	;	:	O	O
h/o	h/o	NN	B-NP	O
carotid	carotid	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
s/p	s/p	NN	I-NP	O
L	L	NN	I-NP	O
CEA	CEA	NN	I-NP	O
2002	2002	CD	I-NP	O
,	,	,	O	O
GERD	GERD	NNP	B-NP	O
;	;	:	O	O
sacral	sacral	JJ	B-NP	O
decubits	decubit	NNS	I-NP	O
ulcer	ulcer	NN	I-NP	O
***	***	SYM	O	O
Admit	Admit	NNP	B-NP	O
meds	med	VBZ	B-VP	O
ASA	ASA	NNP	B-NP	O
325	325	CD	I-NP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
200	200	CD	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
lovenox	lovenox	NN	B-NP	O
80	80	CD	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
fenofibrate	fenofibrate	NN	B-NP	O
145	145	CD	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
40	40	CD	I-NP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
10	10	CD	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
keppra	keppra	NN	B-NP	O
500	500	CD	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
benadryl	benadryl	NN	B-NP	O
25	25	CD	I-NP	O
BID	BID	NN	I-NP	O
prn	prn	NN	I-NP	O
itching	itch	VBG	B-VP	O
,	,	,	O	O
MBI	MBI	NN	B-NP	B-protein
,	,	,	O	O
FeSO4	FeSO4	NN	B-NP	O
325	325	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
trazadone	trazadone	NN	B-NP	B-protein
50	50	CD	I-NP	I-protein
,	,	,	O	O
zantac	zantac	NN	B-NP	O
150	150	CD	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
TP	TP	NN	I-NP	O
***	***	SYM	B-ADJP	O
All	All	DT	O	O
:	:	:	O	O
dilantin	dilantin	NN	B-NP	O
-	-	HYPH	I-NP	O
desquam	desquam	NN	I-NP	O
rash	rash	NN	I-NP	O
***	***	SYM	B-VP	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
96.7	96.7	CD	I-NP	O
HR	HR	NN	I-NP	O
75	75	CD	B-NP	O
BP	BP	NN	I-NP	O
98/54	98/54	CD	B-NP	O
RR	RR	NN	I-NP	O
14	14	CD	B-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
4L	4L	NN	I-NP	O
NAD	NAD	NN	I-NP	O
,	,	,	O	O
anicteric	anicteric	NN	B-NP	O
,	,	,	O	O
OP	OP	NNP	B-NP	O
clear	clear	JJ	I-NP	O
Pulm	Pulm	NN	I-NP	O
-	-	HYPH	B-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
dec.	dec.	NN	B-NP	O
.	.	.	O	O

BS	BS	NN	B-NP	O
at	at	IN	B-PP	O
bases	base	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	VBZ	B-VP	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
distant	distant	JJ	B-NP	O
HS	HS	NN	I-NP	O
,	,	,	O	O
mechanical	mechanical	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
to	to	TO	B-PP	O
jaw	jaw	NN	B-NP	O
+	+	SYM	B-NP	O
BS	BS	NN	I-NP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
NT	NT	NN	I-NP	O
warm	warm	JJ	B-ADJP	O
,	,	,	O	O
dry	dry	JJ	B-ADJP	O
no	no	DT	B-NP	O
rashes	rash	NNS	I-NP	O
awake	awake	VBP	B-VP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	B-ADJP	O
cooperative	cooperative	JJ	I-ADJP	O
,	,	,	O	O
L	L	NN	B-NP	O
sided	side	VBD	B-VP	O
facial	facial	JJ	B-NP	O
droop	droop	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
forearm	forearm	NN	I-NP	O
flexed	flex	VBD	B-VP	O
,	,	,	O	O
moving	move	VBG	B-VP	O
all	all	DT	B-NP	O
four	four	CD	I-NP	O
extrem	extrem	NN	I-NP	O
****	****	SYM	O	O
Admit	Admit	NN	B-NP	B-protein
CXR	CXR	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
diffuse	diffuse	JJ	I-NP	O
B	B	NN	I-NP	O
airspace	airspace	NN	I-NP	O
dz	dz	NN	I-NP	O
,	,	,	O	O
R	R	NN	B-NP	B-protein
>	>	SYM	B-VP	O
L	L	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
effussion	effussion	NN	I-NP	O
,	,	,	O	O
c/w	c/w	NN	B-NP	O
diffuse	diffuse	JJ	I-NP	O
multilobar	multilobar	JJ	I-NP	O
pna	pna	NN	I-NP	O
Echo	Echo	NNP	B-NP	O
9/8	9/8	CD	I-NP	O
LVEF	LVEF	NN	I-NP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
akinesis	akinesis	NN	I-NP	O
of	of	IN	B-PP	O
septum	septum	NN	B-NP	O
,	,	,	O	O
inf	inf	NN	B-NP	O
wall	wall	NN	I-NP	O
,	,	,	O	O
apical	apical	JJ	B-NP	O
lat	lat	JJ	I-NP	O
segment	segment	NN	I-NP	O
,	,	,	O	O
mechanical	mechanical	JJ	B-NP	O
MV	MV	NN	I-NP	O
EKG	EKG	NN	I-NP	O
in	in	IN	B-PP	O
MICU	MICU	NN	B-NP	B-cell_line
-	-	HYPH	B-NP	I-cell_line
sinus	sinus	NN	I-NP	I-cell_line
76	76	CD	I-NP	I-cell_line
***	***	SYM	I-NP	I-cell_line
Consults	Consult	NNPS	I-NP	I-cell_line
Cards	Card	NNPS	I-NP	O
-	-	HYPH	B-NP	O
demand	demand	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
to	to	TO	B-PP	O
stress	stress	NN	B-NP	O
inpatient	inpatient	NN	I-NP	O
,	,	,	O	O
stop	stop	VB	B-VP	O
tracking	track	VBG	I-VP	O
troponins	troponin	NNS	B-NP	O
,	,	,	O	O
can	can	MD	B-VP	O
stress	stress	VB	I-VP	O
as	as	IN	B-PP	O
o/p	o/p	NN	B-NP	O
as	as	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
,	,	,	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
Iuchs	Iuch	NNS	B-NP	O
,	,	,	O	O
add	add	VB	B-VP	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
QD	QD	NN	I-NP	O
***	***	SYM	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
-	-	HYPH	B-ADJP	O
?	?	.	O	O

Multilobar	Multilobar	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
empiric	empiric	JJ	B-NP	O
ceftriaxone	ceftriaxone	NN	I-NP	O
,	,	,	O	O
azithro	azithro	NN	B-NP	O
,	,	,	O	O
vanco	vanco	NN	B-NP	O
in	in	IN	B-PP	O
MICU	MICU	NN	B-NP	B-DNA
.	.	.	O	O

D/c	D/c	NN	B-NP	O
vanco	vanco	NN	I-NP	O
4/10	4/10	CD	I-NP	O
Await	Await	NNP	I-NP	O
BCx	BCx	NN	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
speciation	speciation	NN	I-NP	O
.	.	.	O	O

Afebrile	Afebrile	NN	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
2L	2L	NN	B-NP	O
NC	NC	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
cleared	clear	VBD	B-VP	O
quickly	quickly	RB	B-ADVP	O
,	,	,	O	O
so	so	RB	B-ADVP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
more	more	JJR	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

Completed	Complete	VBN	B-NP	O
short	short	JJ	I-NP	O
7	7	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
azithro	azithro	NN	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
I	I	NN	I-NP	O
:	:	:	O	O
Extensive	Extensive	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
elevated	elevated	JJ	B-NP	O
CK	CK	NN	I-NP	O
,	,	,	O	O
troponin	troponin	NN	B-NP	O
and	and	CC	O	O
new	new	JJ	B-NP	O
LBBB	LBBB	NN	I-NP	B-protein
in	in	IN	B-PP	O
settin	settin	NN	B-NP	O
of	of	IN	B-PP	O
hypoTN	hypoTN	NN	B-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
demand	demand	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

Trended	Trend	VBN	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
,	,	,	O	O
with	with	IN	B-PP	O
troponin	troponin	NN	B-NP	O
remaining	remain	VBG	B-VP	O
elevated	elevate	VBN	I-VP	O
at	at	IN	B-PP	O
5	5	CD	B-NP	O
,	,	,	O	O
but	but	CC	O	O
CK	CK	NN	B-NP	B-protein
mb	mb	NN	I-NP	I-protein
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
18	18	CD	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
.	.	.	O	O

Consulted	Consulted	JJ	B-NP	O
cards	card	NNS	I-NP	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
demand	demand	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LBBB	LBBB	NN	I-NP	O
rate	rate	NN	I-NP	O
dependent	dependent	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

ASA	ASA	NNP	B-NP	O
,	,	,	O	O
Bblocker	Bblocker	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
?	?	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
fibrate	fibrate	NN	B-NP	O
.	.	.	O	O

ON	ON	NN	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
lovenox	lovenox	NN	I-NP	O
for	for	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
.	.	.	O	O

P	P	NN	B-NP	O
:	:	:	O	O
HypoTN	HypoTN	NN	B-NP	O
in	in	IN	B-PP	O
unit	unit	NN	B-NP	O
now	now	RB	B-ADVP	O
resolved	resolve	VBN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
was	be	VBD	B-VP	O
febrile	febrile	JJ	B-ADJP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
unclear	unclear	JJ	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
as	as	IN	B-PP	O
all	all	DT	B-NP	O
cultures	culture	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
?	?	.	O	O

component	component	NN	B-NP	O
of	of	IN	B-PP	O
flash	flash	NN	B-NP	B-protein
pulm	pulm	NN	I-NP	I-protein
edema	edema	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
appears	appear	VBZ	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
to	to	TO	B-VP	O
slightly	slightly	RB	I-VP	O
volume	volume	VB	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

Will	Will	MD	B-VP	O
send	send	VB	I-VP	O
on	on	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
Lasix	Lasix	NNP	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

EF	EF	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
35	35	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
echo	echo	JJ	B-NP	O
R	R	NN	I-NP	O
:	:	:	O	O
New	New	NNP	B-NP	O
LBBB	LBBB	NNP	I-NP	O
in	in	IN	B-PP	O
setting	set	VBG	B-VP	O
of	of	IN	B-PP	O
tachycardia	tachycardia	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
resolves	resolve	VBZ	B-VP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Heme	Heme	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
Had	Have	VBD	B-VP	O
oozing	ooze	VBG	I-VP	O
from	from	IN	B-PP	O
L	L	NN	B-NP	B-DNA
subclavian	subclavian	JJ	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
appears	appear	VBZ	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

Line	Line	NN	B-NP	O
removed	remove	VBD	B-VP	O
on	on	IN	B-PP	O
4/28	4/28	CD	B-NP	O
in	in	IN	B-PP	O
AM	AM	NN	B-NP	B-cell_type
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
-	-	HYPH	I-NP	O
CRI	CRI	NN	I-NP	B-protein
,	,	,	O	O
Cr	Cr	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
1.2-1	1.2-1	CD	B-NP	O
.5	.5	CD	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	AFX	B-NP	B-cell_type
-	-	HYPH	I-NP	O
h/o	h/o	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
CVAs	CVA	NNS	I-NP	B-protein
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
Rx	Rx	NN	B-NP	O
dose	dose	NN	I-NP	O
lovenox	lovenox	NN	I-NP	O
,	,	,	O	O
sz	sz	NN	B-NP	O
disorder	disorder	NN	I-NP	O
-	-	HYPH	B-ADVP	O
On	On	IN	B-PP	O
Keppra	Keppra	NNP	B-NP	O
.	.	.	O	O

Sundowning	Sundowne	VBG	B-VP	O
-	-	:	O	O
on	on	IN	B-PP	O
zyprexa	zyprexa	NN	B-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Endo	Endo	AFX	B-NP	B-protein
-	-	HYPH	I-NP	O
DM	DM	NN	I-NP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
glipizide	glipizide	NN	I-NP	O
held	hold	VBN	B-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
lantus	lantus	NN	B-NP	O
,	,	,	O	O
lispro	lispro	NN	B-NP	O
SS	SS	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
very	very	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
so	so	RB	O	O
d/c	d/c	NN	B-NP	O
`	`	``	O	O
ed	ed	VBN	B-VP	O
glipizide	glipizide	NN	B-NP	O
and	and	CC	O	O
sending	send	VBG	B-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
with	with	IN	B-PP	O
AC	AC	NN	B-NP	O
novolog	novolog	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Prophy	Prophy	NN	B-NP	O
-	-	HYPH	I-NP	O
Therapeutic	Therapeutic	JJ	I-NP	O
lovenox	lovenox	NN	I-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
-	-	HYPH	I-NP	O
FULL	FULL	NN	I-NP	O
CODE	CODE	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

Check	Check	NNP	B-NP	O
weight	weight	NN	I-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
avoid	avoid	VB	B-VP	O
high	high	JJ	B-NP	O
salt	salt	NN	I-NP	O
foods	food	NNS	I-NP	O
-	-	:	O	O
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
increases	increase	VBZ	B-VP	O
by	by	IN	B-PP	O
>	>	JJR	B-NP	O
2	2	CD	I-NP	O
lbs	lb	NNS	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
or	or	CC	O	O
5	5	CD	B-NP	O
lbs	lb	NNS	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
contact	contact	VB	B-VP	O
your	your	PRP$	B-NP	O
physician	physician	NN	I-NP	O
to	to	TO	B-VP	O
consider	consider	VB	I-VP	O
increasing	increase	VBG	I-VP	O
your	your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
Continue	Continue	NN	I-NP	O
treatment	treatment	NN	I-NP	O
dose	dose	NN	I-NP	O
lovenox	lovenox	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
STORTON	STORTON	NN	B-NP	O
,	,	,	O	O
ERNEST	ERNEST	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KR30	KR30	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/25/06	10/25/06	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

